Alert detail
FDA Approval: TRELSTAR (TRIPTORELIN PAMOATE) — Type 3 - New Dosage Form
Policy ID: FDA-NDA022437Specialty: OncologyAdded: 7/1/2026Effective: 2010-03-10billing update
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.